John G. Gums - Concepedia

Author

John G. Gums

Also Known As

Eric Boerwinkle, G. A. FitzGerald, Garret A. FitzGerald, J G Gums, J Gums, J. G. Gums, JG Gums, JOHN G. GUMS, John G Gums, John G. Gums

213

Publications

4.5K

Citations

H-Index

118

Concepts

All Affiliations

University of Florida Mayo Clinic The University of Texas Health Science Center at Houston Emory University University of Maryland, Baltimore

About

John G. Gums is an author at University of Florida specializing in medicine, hypertension, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	955
2	Health Sciences	7	7	222
3	Public Health	7	7	349
4	Engineering	1	1	35
5	Nursing	1	1	81

John G. Gums

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Outcome Analysis of a Pharmacist‐Managed Anticoagulation Service Vickie M. Wilt, John G. Gums, Leah M. Moore Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	1995	161
A Randomized, Prospective Study Measuring Outcomes after Antibiotic Therapy Intervention by a Multidisciplinary Consult Team John G. Gums, Robert W. Yancey, Carol A. Hamilton, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	1999	123
Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study Julie A. Johnson, Eric Boerwinkle, Issam Zineh, American Heart Journal HypertensionAntihypertensive ResponsesAntihypertensive TherapyPharmacologyPharmacogenomic Evaluation	2009	122
Genomic Association Analysis of Common Variants Influencing Antihypertensive Response to Hydrochlorothiazide Stephen T. Turner, Eric Boerwinkle, Jeffrey R. O’Connell, Hypertension HypertensionGeneticsGenetic EpidemiologyHuman PolymorphismPharmacotherapy	2013	108
Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate Issam S. Hamadeh, Taimour Langaee, R. Dwivedi, Clinical Pharmacology & Therapeutics	2014	107
Plasma Renin Activity Predicts Blood Pressure Responses to -Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension S. T. Turner, G. L. Schwartz, Arlene B. Chapman, American Journal of Hypertension	2010	100
Pharmacogenomics of Hypertension: A Genome‐Wide, Placebo‐Controlled Cross‐Over Study, Using Four Classes of Antihypertensive Drugs Timo P. Hiltunen, Kati Donner, Antti‐Pekka Sarin, Journal of the American Heart Association HypertensionGeneticsGenetic EpidemiologyHuman PolymorphismPharmacotherapy	2015	82
The benefits of physician-pharmacist collaboration. Andrew Y. Hwang, Tyler H. Gums, John G. Gums PubMed NursingFamily MedicineHypertensionPrimary CareHealth Policy	2017	81
Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive Medications Rhonda M. Cooper‐DeHoff, Sheron Wen, Amber L. Beitelshees, Hypertension HypertensionMetabolic DisorderHyperlipidemiaNew-onset Diabetes MellitusObesity	2009	76
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics Caitrin W. McDonough, Sarah E. Burbage, Julio D. Duarte, Journal of Hypertension	2013	74

Page 1